Notify me when Sandra Calvin files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | Svp, Chief Accounting Officer | $1,576,449 | -$2,956,156 | -65% | 31 Jan 2026 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|